Elevai Labs
ELAB
3 hedge funds and large institutions have $4.06K invested in Elevai Labs in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.02% → 0% (-0.02%)
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
93% less capital invested
Capital invested by funds: $57.7K → $4.06K (-$53.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.6K |
| 2 |
Citigroup
New York
|
+$1.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$38.5K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$11.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.49K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $2.45K | +$1.6K | +10 | +111% |
|
|
2
Citigroup
New York
| $973 | +$1.28K | +8 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $619 | -$4.49K | -28 | -85% |
|
4
Bank of America
Charlotte,
North Carolina
| $21 | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$38.5K | -212 | Closed |
|
|
SM
6
Sabby Management
Miami Beach,
Florida
| – | -$11.5K | -63 | Closed |
|
ELAB Hedge Fund Activity: Q3 2025 in Review
3 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Elevai Labs (ELAB) for Q3 2025, worth a combined $4.06K — down 93% from $57.7K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ELAB and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $1.6K. The largest seller was Citadel Advisors, exiting entirely with an estimated $38.5K sold.
- 3 institutional investors held Elevai Labs (ELAB) as of Q3 2025, down from 4 in Q2 2025.
- Funds reported $4.06K of Elevai Labs stock for Q3 2025, down 93% quarter-over-quarter.
- 1 fund opened new Elevai Labs positions in Q3 2025 and 2 closed out, a net change of -1 holder.
- The largest Elevai Labs buyer in Q3 2025 was Tower Research Capital (TRC), an estimated $1.6K added.
- The largest Elevai Labs seller in Q3 2025 was Citadel Advisors, an estimated $38.5K sold.
Based on aggregated 13F filings for Q3 2025.